Preoperative Imaging for Metastasectomy

Surgical Oncology Clinics of North America

Volumn 16, Issue 3, 2007, Pages 471-492

  Klippenstein, Donald L ^a,b   Lamonica, Dominick M ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; CONTRAST MEDIUM; FLUORINE 18; GADOLINIUM; YTTRIUM 90;

ADRENAL METASTASIS; CANCER STAGING; CANCER SURGERY; COLORECTAL CARCINOMA; ENDOCRINE TUMOR; GASTROINTESTINAL TUMOR; HUMAN; IMAGING SYSTEM; LIVER METASTASIS; LUNG METASTASIS; MELANOMA; PERITONEUM CANCER; PREOPERATIVE EVALUATION; REVIEW; SARCOMA;

ADRENAL GLAND NEOPLASMS; BONE NEOPLASMS; CARCINOMA; COLORECTAL NEOPLASMS; CONTRAST MEDIA; DIAGNOSTIC IMAGING; DIGESTIVE SYSTEM NEOPLASMS; ENTEROENDOCRINE CELLS; FLUORODEOXYGLUCOSE F18; HUMANS; INTRAOPERATIVE CARE; LIVER NEOPLASMS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; NEOPLASM METASTASIS; PERITONEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SARCOMA; SOFT TISSUE NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34347258905     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2007.04.004     Document Type: Review

References (138)

1. Muhm J.R., Brown L.R., and Crowe J.K. Detection of pulmonary nodules by computed tomography. AJR Am J Roentgenol 128 2 (1977) 267-270
2. Wormanns D., Ludwig K., Beyer F., et al. Detection of pulmonary nodules at multirow-detector CT: effectiveness of double reading to improve sensitivity at standard-dose and low-dose chest CT. Eur Radiol 15 1 (2005) 14-22
3. Weng M.J., Wu M.T., Pan H.B., et al. The feasibility of low-dose CT for pulmonary metastasis in patients with primary gynecologic malignancy. Clin Imaging 28 6 (2004) 408-414
4. Remy-Jardin M., Remy J., Giraud F., et al. Pulmonary nodules: detection with thick-section spiral CT versus conventional CT. Radiology 187 2 (1993) 513-520
5. Paranjpe D.V., and Bergin C.J. Spiral CT of the lungs: optimal technique and resolution compared with conventional CT. AJR Am J Roentgenol 162 3 (1994) 561-567
6. Buckley J.A., Scott Jr. W.W., Siegelman S.S., et al. Pulmonary nodules: effect of increased data sampling on detection with spiral CT and confidence in diagnosis. Radiology 196 2 (1995) 395-400
7. Diederich S., Semik M., Lentschig M.G., et al. Helical CT of pulmonary nodules in patients with extrathoracic malignancy. AJR Am J Roentgenol 172 (1999) 353-360
8. Parsons A.M., Detterbeck F.C., and Parker L.A. Accuracy of helical CT in the detection of pulmonary metastases: is intraoperative palpation still necessary?. Ann Thorac Surg 78 6 (2004) 1910-1916 [discussion: 1916-8]
9. Kayton M.L., Huvos A.G., Casher J., et al. Computed tomographic scan of the chest underestimates the number of metastatic lesions in osteosarcoma. J Pediatr Surg 41 (2006) 200-206
10. Tillich M., Kammerhuber F., Reittner P., et al. Detection of pulmonary nodules with helical CT: comparison of cine and film-based viewing. AJR Am J Roentgenol 169 (1997) 1611-1614
11. Gruden J.F., Ouanounou S., Tigges S., et al. Incremental benefit of maximum-intensity-projection images on observer detection of small pulmonary nodules revealed by multidetector CT. AJR Am J Roentgenol 179 (2002) 149-157
12. Valencia R., Denecke T., Lehmkuhl L., et al. Value of axial and coronal maximum intensity projection (MIP) images in the detection of pulmonary nodules by multislice spiral CT: comparison with axial 1-mm and 5-mm slices. Eur Radiol 16 (2006) 325-332
13. Rubin G.D., Lyo J.K., Paik D.S., et al. Pulmonary nodules on multi-detector row CT scans: performance comparison of radiologists and computer-aided detection. Radiology 234 (2005) 274-283
14. Wormanns D., Beyer F., Diederich S., et al. Diagnostic performance of a commercially available computer-aided diagnosis system for automatic detection of pulmonary nodules: comparison with single and double reading. Rofo 176 7 (2004) 953-958
15. Kim J.S., Kim J.H., Cho G., et al. Automated detection of pulmonary nodules on CT images: effect of section thickness and reconstruction interval-initial results. Radiology 236 (2005) 295-299
16. Gurung J., Maataoui A., Khan M., et al. Automated detection of lung nodules in multidetector CT: influence of different reconstruction protocols on performance of a software prototype. Rofo 178 1 (2006) 71-77
17. Lee J.W., Goo J.M., Lee H.J., et al. The potential contribution of a computer-aided detection system for lung nodule detection in multidetector row computed tomography. Invest Radiol 39 (2004) 649-655
18. Yuan R., Vos P.M., and Cooperberg P.L. Computer-aided detection in screening CT for pulmonary nodules. AJR Am J Roentgenol 18 (2006) 1280-1287
19. Bae K.T., Kim J.S., Na Y.H., et al. Pulmonary nodules: automated detection on CT images with morphologic matching algorithm-preliminary results. Radiology 236 (2005) 286-294
20. Swensen S.J., Viggiano R.W., Midthun D.E., et al. Lung nodule enhancement at CT: multicenter study. Radiology 214 (2000) 73-80
21. Goodman L.R., Gulsun M., Washington L., et al. Inherent variability of CT lung nodule measurements in vivo using semiautomated volumetric measurements. AJR Am J Roentgenol 186 (2006) 989-994
22. Revel M.P., Bissery A., Bienvenu M., et al. Are two-dimensional CT measurements of small noncalcified pulmonary nodules reliable?. Radiology 231 (2004) 453-458
23. Kostis W.J., Yankelevitz D.F., Reeves A.P., et al. Small pulmonary nodules: reproducibility of three-dimensional volumetric measurement and estimation of time to follow-up CT. Radiology 231 (2004) 446-452
24. Gould M.K., Maclean C.C., Kuschner W.G., et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 285 7 (2001) 914-924
25. Nie Y., Li Q., Li F., et al. Integrating PET and CT information to improve diagnostic accuracy for lung nodules: a semiautomatic computer-aided method. J Nucl Med 47 (2006) 1075-1080
26. Pfannschmidt J., Klode J., Muley T., et al. Nodal involvement at the time of pulmonary metastasectomy: experiences in 245 patients. Ann Thorac Surg 81 (2006) 448-454
27. Ercan S., Nichols F.C., Trastek V.F., et al. Prognostic significance of lymph node metastasis found during pulmonary metastasectomy for extrapulmonary carcinoma. Ann Thorac Surg 77 (2004) 1786-1791
28. Schroeder T., Ruehm S.G., Debatin J.F., et al. Detection of pulmonary nodules using a 2D HASTE MR sequence: comparison with MDCT. AJR Am J Roentgenol 185 (2005) 979-984
29. Johnson P.T., and Fishman E.K. IV contrast for MDTC: current thoughts and practice. AJR Am J Roentgenol 186 (2006) 406-415
30. Weg N., Scheer M.R., and Gabor M.P. Liver lesions: improved detection with dual-detector-array CT and routine 2.5-mm thin collimation. Radiology 209 (1998) 417-426
31. Haider M.A., Amitai M.M., Rappaport D.C., et al. Multi-detector row helical CT in preoperative assessment of small (≤1.5 cm) liver metastases: Is thinner collimation better?. Radiology 225 (2002) 137-142
32. Bhattacharjya S., Bhattacharjya T., Baber S., et al. Prospective study of contrast-enhanced computed tomography, computed tomography during arterioportography, and magnetic resonance imaging for staging colorectal liver metastases for liver resection. Br J Surg 91 (2004) 1361-1369
33. Ward J., Naik K.S., Guthrie J.A., et al. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. Radiology 210 (1999) 459-466
34. Reimer P., Jahnke N., Fiebich M., et al. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT: ROC analysis. Radiology 217 (2000) 152-158
35. Oudkerk M., Torres C.G., Song B., et al. Characterization of liver lesion with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT. Radiology 223 (2002) 517-524
36. Kim K.W., Kim A.Y., Kim T.K., et al. Small (≤2 cm) hepatic lesions in colorectal cancer patients: detection and characterization on mangafodipir trisodium-enhanced MRI. AJR Am J Roentgenol 182 (2004) 1233-1240
37. Soyer P., Poccard M., Boudiaf M., et al. Detection of hypovascular hepatic metastases at triple-phase helical CT: sensitivity of phases and comparison with surgical and histopathologic findings. Radiology 231 (2004) 413-420
38. Ward J., Robinson P.J., Guthrie J.A., et al. Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO- enhanced MR imaging. Radiology 237 (2005) 170-180
39. Holalkere N.S., Sahani D.V., Blake M.A., et al. Characterization of small liver lesions: added role of MR after MDCT. J Comput Assist Tomogr 30 4 (2006) 591-596
40. Numminen K., Isoniemi H., Halavaara J., et al. Preoperative assessment of focal liver lesions: multidetector computed tomography challenges magnetic resonance imaging. Acta Radiol 46 1 (2005) 9-15
41. Onishi H., Murakami T., Kim T., et al. Hepatic metastases: detection with multi-detector row CT, SPIO-enhanced MR imaging, and both techniques combined. Radiology 239 1 (2006) 131-138
42. Ward J., Guthrie J.A., Wilson D., et al. Colorectal hepatic metastases: detection with SPIO-enhanced breath-hold MR imaging: comparison of optimized sequences. Radiology 228 (2003) 709-718
43. Ward J. New MR techniques for the detection of liver metastases. Cancer Imaging 6 (2006) 33-42
44. Kim Y.K., Lee J.M., Kim C.S., et al. Detection of liver metastases: gadobenate dimeglumine-enhanced three-dimensional dynamic phases and one-hour delayed phase MR imaging versus superparamagnetic iron oxide-enhanced MR imaging. Eur Radiol 15 2 (2005) 220-228
45. Chung J.J., Kim M.J., and Kim K.W. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?. J Magn Reson Imaging 23 5 (2006) 706-711
46. Bartolozzi C., Donati F., Cioni D., et al. Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT. Eur Radiol 14 (2004) 14-20
47. Vogl T.J., Schwarz W., and Blume S. Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US. Eur Radiol 13 (2003) 262-272
48. Vidiri A., Carpanese L., D'Annibale M., et al. Evaluation of hepatic metastases from colorectal carcinoma with MR-superparamagnetic iron oxide. J Exp Clin Cancer Res 23 1 (2004) 53-60
49. Del Frate C., Bazzocchi M., and Mortele K.J. Detection of liver metastases: comparison of gadobenate dimeglumine-enhanced and ferumoxides-enhanced MR imaging examinations. Radiology 225 (2002) 766-772
50. Vogl T.J., Hammerstingl R., Schwarz W., et al. Magnetic resonance imaging of focal liver lesions: comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient. Invest Radiol 31 11 (1996) 696-708
51. Kim M.J., Kim J.H., Lim J.S., et al. Detection and characterization of focal hepatic lesions: mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging. J Magn Reson Imaging 20 4 (2004) 612-621
52. Choi J.Y., Kim M.J., and Kim J.H. Detection of hepatic metastasis: manganese- and ferucarbotran-enhanced MR imaging. Eur J Radiol 60 1 (2006) 84-90
53. Kim H.J., Kim K.W., Byun J.H., et al. Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients. AJR Am J Roentgenol 186 (2006) 1059-1066
54. van Etten B., van der Sijp J.R.M., Kruyt R.H., et al. Ferumoxide-enhanced magnetic resonance imaging techniques in pre-operative assessment for colorectal liver metastases. Eur J Surg Oncol 28 (2002) 645-651
55. Semelka R.C., Cance W.G., Marcos H.B., et al. Liver metastases: comparison of current MR techniques and spiral CT during arterial portography for detection in 20 surgically staged cases. Radiology 312 1 (1999) 86-91
56. Hosch W.P., Schmidt S.M., and Plaza S. Comparison of CT during arterial portography and MR during arterial portography in the detection of liver metastases. AJR Am J Roentgenol 186 (2006) 1502-1511
57. Jarnagin W.R., Bach A.M., Winston C.B., et al. What is the yield of intraoperative ultrasonography during partial hepatectomy for malignant disease?. J Am Coll Surg 192 (2001) 577-583
58. Zacherl J., Scheuba C., Imhof M., et al. Current value of intraoperative sonography during surgery for hepatic neoplams. World J Surg 26 (2002) 550-554
59. Leen E., Ceccotti P., Moug S.J., et al. Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases. Ann Surg 243 (2006) 236-240
60. Kinkel K., Lu Y., Both M., et al. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 224 (2002) 748-756
61. 18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases. Br J Surg 92 (2005) 362-369
62. Wiering B., Ruers T.J.M., Krabbe P.F.M., et al. Comparison of multiphase CT, FDG-PET and intra-operative ultrasound in patients with colorectal liver metastases selected for surgery. Ann Surg Oncol 14 2 (2007) 818-826
63. Ghanem N., Altehoefer C., Hogerle S., et al. Detectability of liver metastases in malignant melanoma: prospective comparison of magnetic resonance imaging and positron emission tomography. Eur J Radiol 54 2 (2005) 264-270
64. Sahani D.V., Kalva S.P., Fischman A.J., et al. Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET. AJR Am J Roentgenol 185 (2005) 239-246
65. Seemann M.D., Meisetschlaeger G., Gaa G., et al. Assessment of the extent of metastases of gastrointestinal carcinoid tumors using whole-body PET, CT, MRI, PET/CT and PET/MRI. Eur J Med Res 11 2 (2006) 58-65
66. Schmidt G.P., Baur-Melnyk A., Herzog P., et al. High-resolution whole- body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography. Invest Radiol 40 (2005) 743-753
67. Hedeland H., Ostberg G., and Hokfelt B. On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Med Scand 184 3 (1968) 211-214
68. Blake M.A., Kalra M.K., Sweeney A., et al. Distinguishing benign from malignant adrenal masses: multi-detector row CT Protocol with 10-minute delay. Radiology 238 2 (2006) 578-586
69. Caoili E.M., Korobkin M., Francis I.R., et al. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 222 (2002) 629-633
70. Korobkin M., Brodeur F.J., Yutzy G.G., et al. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR Am J Roentgenol 166 3 (1996) 531-536
71. Boland G.W., Lee M.J., Gazelle G.S., et al. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol 171 1 (1998) 201-204
72. Savci G., Yazici Z., Sahin N., et al. Value of chemical shift subtraction MRI in characterization of adrenal masses. AJR Am J Roentgenol 186 (2006) 130-135
73. Tsushima Y., Ishizaka H., and Matsumoto M. Adrenal masses: differentiation with chemical shift, fast low-angle shot MR imaging. Radiology 186 (1993) 705-709
74. Haider M.A., Ghai S., Jhaveri K., et al. Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role?. Radiology 231 (2004) 711-716
75. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med 42 (2001) 1795-1799
76. Maurea S., Mainolfi C., Bazzicalupo L., et al. Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions. AJR Am J Roentgenol 173 (1999) 25-29
77. Boland G.W., Goldberg M.A., Lee M.J., et al. Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 194 (1995) 131-134
78. Blake M.A., Slattery J.M., Kalra M.K., et al. Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy: initial experience. Radiology 238 3 (2006) 970-977
79. Wiering B., Krabbe P.F.M., Jager G.J., et al. The impact of Fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases. Cancer 104 (2005) 2658-2670
80. Wiering B., Krabbe P.F.M., Dekker H.M., et al. The role of FDG-PET in the selection of patients with colorectal liver metastases. Ann Surg Oncol 2 14 (2007) 771-779
81. Fernandez F.G., Drebin J.A., Linehan D.C., et al. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 Fluorodeoxyglucose (FDG-PET). Ann Surg 240 (2004) 438-450
82. Flanagan F.L., Dehdashti F., Ogunbiyi O.A., et al. Utility of FDG-PET for Investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg 227 3 (1998) 319-323
83. Whiteford M.H., Whiteford H.M., Yee L.F., et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum 43 6 (2000) 759-767 [discussion: 767-70]
84. Essner R., Belhocine T., Scott A.M., et al. Novel imaging techniques in melanoma. Surg Oncol Clin N Am 15 (2006) 253-283
85. Finkelstein S.E., Carrasquillo J.A., Hoffman J.M., et al. A prospective analysis of positron emission tomography and conventional imaging for detection of stage IV metastatic melanoma in patients undergoing metastasectomy. Ann Surg Oncol 11 8 (2004) 731-738
86. Swetter S.M., Carroll L.A., Johnson D.L., et al. Positron emission tomography is superior to computed tomography for metastatic detection in melanoma patients. Ann Surg Oncol 9 7 (2002) 646-3
87. Muller-Horvat C., Radny P., Eigentler T.K., et al. Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma. Eur J Cancer 42 3 (2006) 342-350
88. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. Eur J Cancer 43 (2007) 557-564
89. 18F-FDG PET/C imaging for N- and M- staging of malignant melanoma: experience with 250 consecutive patients. J Clin Oncol 24 (2006) 1178-1187
90. Blake S.P., Weisinger K., Atkins M.B., et al. Liver metastases from melanoma: detection with multiphasic contrast-enhanced CT. Radiology 213 1 (1999) 92-96
91. Kaltsas G., Rockall A., Papadogias D., et al. Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours. Eur J Endocrinol 151 (2004) 15-27
92. Jadvar H., and Segall G.M. False-negative fluorine-18-FDG PET in metastatic carcinoid. J Nucl Med 38 9 (1997) 1382-1383
93. Belhocine T., Foidart J., Rigo P., et al. Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67. Nucl Med Commun 23 8 (2002) 727-734
94. 18F-DOPA PET: a prospective, diagnostic accuracy study. Lancet Oncol 7 (2005) 728-734
95. Pfannenberg A.C., Eschmann S.M., Horger M., et al. Benefit of anatomical-functional image fusion in the diagnostic work-up of neuroendocrine neoplasms. Eur J Nucl Med Mol Imaging 30 (2003) 835-843
96. Gouya H., Vignaux O., Augui J., et al. CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas. AJR Am J Roentgenol 181 (2003) 987-992
97. Paulson E.K., McDermott V.G., Keogan M.T., et al. Carcinoid metastases to the liver: role of triple-phase helical CT. Radiology 206 (1998) 143-150
98. Dromain C., de Baere T., Lumbroso J., et al. Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging. J Clin Oncol 23 (2005) 70-78
99. Virgolini I., Traub-Weidinger T., and Decristoforo C. Nuclear medicine in the detection and management of pancreatic islet-cell tumours. Best Pract Res Clin Endocrinol Metab 19 2 (2005) 213-227
100. 11C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography. J Clin Endocrinol Metab 90 6 (2005) 3392-3400
101. Becherer A., Szabo M., Karanikas G., et al. Imaging of advanced neuroendocrine tumors with 18F-FDOPA PET. J Nucl Med 45 7 (2004) 1161-1167
102. Iagaru A., Chawla S., Menendez L., et al. F-FDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas. Nucl Med Commun 27 (2006) 795-802
103. Johnson G.R., Zhuang H., Khan J., et al. Roles of positron emission tomography with fluorine-18-deoxyglucose in the detection of local recurrent and distant metastatic sarcoma. Clin Nucl Med 28 (2003) 815-820
104. Daldrup-Link H., Franzius C., Link T.M., et al. Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. AJR Am J Roentgenol 177 (2001) 229-236
105. Kneisl J.S., Patt J.C., and Johnson J.C. Is PET useful in detecting occult nonpulmonary metastases in pediatric bone sarcomas?. Clin Orthop Relat Res 450 (2006) 101-104
106. Jacquet P., Jelinek J.S., Steves M.A., et al. Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer 72 5 (1993) 1631-1636
107. De Bree E., Koops W., Kroger R., et al. Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraopertaive findings and evaluation of interobserver agreement. J Surg Oncol 86 (2004) 64-73
108. Gretschel S., Siegel R., Estevez-Schwarz L., et al. Surgical strategies for gastric cancer with synchronous peritoneal carcinomatosis. Br J Surg 93 (2006) 1530-1535
109. Frasci G., Contino A., Iaffaioli R.V., et al. Computerized tomography of the abdomen and pelvis with peritoneal administration of soluble contrast (IPC-CT) in detection of residual disease for patients with ovarian cancer. Gynecol Oncol 52 2 (1994) 154-160
110. Caseiro-Alves F., Goncalo M., Abraul E., et al. Induced pneumoperitoneum in CT evaluation of peritoneal carcinomatosis. Abdom Imaging 20 1 (1995) 52-55 [discussion: 56-7]
111. Gryspeerdt S., Clabout L., Van Hoe L., et al. Intraperitoneal contrast material combined with CT for detection of peritoneal metastases of ovarian cancer. Eur J Gynaecol Oncol 19 5 (1998) 434-437
112. Coakley F.V., Choi P.H., Gougoutas C.A., et al. Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology 223 (2002) 495-499
113. Pannu H.K., Horton K.M., and Fishman E.K. Thin section dual-phase multidetector-row computed tomography detection of peritoneal metastases in gynecologic cancers. J Comput Assist Tomogr 27 3 (2003) 333-340
114. Qayyum A., Coakley F.V., Westphalen A.C., et al. Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. Gynecol Oncol 96 (2005) 301-306
115. Dowdy S.C., Mullany S.A., Brandt K.R., et al. The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma. Cancer 101 (2004) 346-352
116. de Bree E., Koops W., Kroger R., et al. Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 32 (2006) 65-71
117. Yan T.D., Haveric N., and Carmignani C.P. Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Cancer 103 (2005) 839-849
118. Tempany C.M.C., Zou K.H., and Silverman S.G. Staging of advanced ovarian cancer: comparison of imaging modalities: report from the Radiological Diagnostic Oncology Group. Radiology 215 (2000) 761-767
119. Low R.N., Semelka R.C., Worawattanakul S., et al. Extrahepatic abdominal imaging in patients with malignancy: comparison of MR imaging and helical CT, with subsequent surgical correlation. Radiology 210 (1999) 625-632
120. Cotton F., Pellet O., Gilly F.N., et al. MRI evaluation of bulky tumor masses in the mesentery and bladder involvement in peritoneal carcinomatosis. Eur J Surg Oncol 32 (2006) 1212-1216
121. Low R.N., Barone R.M., Lacey C., et al. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT. Radiology 204 (1997) 513-520
122. Balestreri L., Bison L., Sorio R., et al. Abdominal recurrence of ovarian cancer: value of abdominal MR in patients with positive CA 125 and negative CT. Radiol Med (Torino) 104 5-6 (2002) 426-436
123. Koh D.M., Brown G., Temple L., et al. Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings: initial observations. Radiology 231 1 (2004) 91-99
124. Anzai Y., Piccoli C.W., Outwater E.K., et al. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology 228 3 (2003) 777-788
125. Saksena M.A., Saokar A., and Harisinghani M.G. Lymphotropic nanoparticle enhanced MR imaging (LNMRI) technique for lymph node imaging. Eur J Radiol 58 (2006) 367-374
126. Lim J.S., Kim M.J., Yun M.J., et al. Comparison of CT and 18F-FDG PET for detecting peritoneal metastasis on the preoperative evaluation for gastric carcinoma. Korean J Radiol 7 4 (2006) 249-256
127. Drieskens O., Stroobants S., Gysen M., et al. Positron emission tomography with FDG in the detection of peritoneal and retroperitoneal metastases of ovarian cancer. Gynecol Obstet Invest 55 3 (2003) 130-134
128. Pannu H.K., Cohade C., Bristow R.E., et al. PET-CT detection of abdominal recurrence of ovarian cancer: radiologic-surgical correlation. Abdom Imaging 39 (2004) 398-403
129. Turlakow A., Yeung H., Walmon H.W., et al. Peritoneal carcinomatosis role of (18) F-FDG PET. J Nucl Med 44 9 (2003) 1407-1412
130. Suzuki A., Kawano T., Takahashi N., et al. Value of 18F-FDG PET in the detection of peritoneal carcinomatosis. Eur J Nucl Med Mol Imaging 31 10 (2004) 1413-1420
131. Picchio M., Sironi S., Messa C., et al. Advanced ovarian carcinoma: usefulness of [(18)F] FDG-PET in combination with CT for lesion detection after primary treatment. Q J Nucl Med 47 (2003) 77-84
132. Yang Q.M., Bando E., Kawamura T., et al. The diagnostic value of PET-CT for peritoneal dissemination of abdominal malignancies. Gan To Kagaku Ryoho 33 12 (2006) 1817-1821
133. Sironi S., essa C., Mangili G., et al. Integrated FDG PET/CT in patients with persistent ovarian cancer: correlation with histologic findings. Radiology 233 (2004) 433-440
134. Bristow R.E., del Carmen M.G., Pannu H.K., et al. Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT. Gynecol Oncol 90 (2003) 519-528
135. Havrilesky L.J., Kulasingam S.L., Matchar D.B., et al. FDG-PET for management of cervical and ovarian cancer. Gynecol Oncol 97 (2005) 183-191
136. Cho S.M., Ha H.K., Byun J.Y., et al. Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer. AJR Am J Roentgenol 179 (2002) 391-395
137. Nakamoto Y., Safa T., Ishimori T., et al. Clinical value of positron emission tomography with FDG for recurrent ovarian cancer. AJR Am J Roentgenol 176 (2001) 1449-1454
138. Rose P.G., Faulhaber P., Miraldi F., et al. Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy. Gynecol Oncol 82 (2001) 17-21